Biography and Research Information
OverviewAI-generated summary
Katherine Cruse's research focuses on the intersection of molecular biology and immunotherapy, specifically investigating how to enhance the efficacy of CAR-T cell therapy. Her recent work explores manipulating the DNA damage response to combat T cell exhaustion, a key limitation in achieving durable responses to immunotherapy. Cruse also studies the donor-intrinsic proteomic programs that influence CAR-T cell persistence, examining the molecular mechanisms that govern their long-term survival and anti-cancer activity. These investigations are conducted in collaboration with researchers at the University of Arkansas for Medical Sciences, including Brian Koss, Jessica L. Kelliher, Daniel Fil, and Lora J. Rogers, with whom she shares multiple publications.
Metrics
- Publications: 1
Selected Publications
-
236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response (2025)
-
392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay (2025)
Collaboration Network
Top Collaborators
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 392 Donor-intrinsic proteomic programs shape CAR-T cell persistence across a longitudinal killing assay
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
- 236 Manipulating the DNA damage response to combat T cell exhaustion and improve immunotherapy response
Similar Researchers
Based on overlapping research topics